Depression and coronary artery disease: Time to move from observation to trials

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 5, 2003, Pages 570-571

  Lespérance, François ^a   Frasure Smith, Nancy ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; SEROTONIN UPTAKE INHIBITOR;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; MENTAL DISEASE; MORTALITY; NOTE; RISK FACTOR; SURVIVAL RATE; SYMPTOMATOLOGY;

EID: 0037418343     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-17.
2. Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systemic review of prospective cohort studies. BMJ 1999;318:1460-7.
3. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155(1):4-11.
4. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049-53.
5. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613-7.
6. Penninx BWJ, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, von Eijk JTM, et al. Depression and cardiac mortality. Results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-7.
7. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch Gen Psychiatry 1998;55:580-92.
8. Krishnan KRR, McDonald WM. Arteriosclerotic depression. Med Hypotheses 1995;44:111-5.
9. Appels A, Bär FW, Bár J, Bruggeman C, De Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000;62:601-5.
10. Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, aging and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 1999;60:217-34.
11. Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001;63(2):221-30.
12. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000;62:212-9.
13. Lauzon C, Beck CA, Huynh T, Dion D, Racine N, Carignan S, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ 2003;168(5):547-52.
14. Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S, Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001;103(15):1933-5.
15. Berkman LF, Jaffe AS, for the ENRICHD investigators. The effects of treating depression and low social support on clinical events after a myocardial infarction. Circulation 2001;104(1B):2.
16. Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91(4):999-1005.
17. Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG. Gender, depression and one-year prognosis after myocardial infarction. Psychosom Med 1999;61:26-37.
18. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160:1354-60.
19. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001;161:1849-56.
20. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease: a 12-month follow-up. Gen Hosp Psychiatry 1996;18:61-5.
21. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001;358:1766-71.
22. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States. Using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002;59:115-23.
23. Glassman AH, O'Connor CM, Califf R, Swedberg K, Schwartz P, Bigger JT Jr., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288(6):701-9.